Stock Code
603707.SH
ABOUT
>
Company profile
Enterprise Culture
Early Warning System
BUSINESS
>
Commercialized Products
MEDIA
>
News in NKF
CONTACT
CH / EN
Home
>
MEDIA
>
News in NKF
>
Paclitaxel For Injection (Albumin Bound) approved by US FDA
2025-05-20
Paclitaxel For Injection (Albumin Bound) approved by US FDA
share
Return
Previous
King-Friend will meet you in CPHI Frankfurt!
Next
NKF's subsidiary Kindos's Mitoxantrone Injection gets FDA approval for marketing
Relevant recommendations
2025-05-26
NKF's subsidiary Kindos's Idarubicin Hydrochloride Injection gets FDA approval for marketing
2025-05-22
NKF's subsidiary Kindos's Mitoxantrone Injection gets FDA approval for marketing
2025-05-19
King-Friend will meet you in CPHI Frankfurt!
2025-05-13
King-Friend will meet you in CPHI Shanghai!
2025-04-04
NKF's Liraglutide Injection gets FDA approval for marketing
